References
1. Honore PM, Jacobs R, Joannes-Boyau O, Verfaillie L, De Regt J, Van Gorp V, et al. Biomarkers for early diagnosis of AKI in the ICU: Ready for prime time use at the bedside? Ann Intensive Care 2012;2:24.Search in Google Scholar
2. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: A multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011;57:1752-61.10.1016/j.jacc.2010.11.051Search in Google Scholar PubMed PubMed Central
3. Haase M, Kellum JA, Ronco C. Subclinical AKI--an emerging syndrome with important consequences. Nat Rev Nephrol 2012;8:735-9.10.1038/nrneph.2012.197Search in Google Scholar PubMed
4. Ronco C, Kellum JA, Haase M. Subclinical AKI is still AKI. Crit Care 2012;16:313.10.1186/cc11240Search in Google Scholar PubMed PubMed Central
5. Ronco C, Stacul F, McCullough PA. Subclinical acute kidney injury (AKI) due to iodine-based contrast media. Eur Radiol 2013;23:319-23.10.1007/s00330-012-2607-ySearch in Google Scholar PubMed
6. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013;17:R25.10.1186/cc12503Search in Google Scholar PubMed PubMed Central
7. Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, et al. Sapphire Investigators. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant 2014;29:2054-61.10.1093/ndt/gfu292Search in Google Scholar PubMed PubMed Central
8. Prucha M, Bellingan G, Zazula R. Sepsis biomarkers. Clin Chim Acta 2014;440:97-103.10.1016/j.cca.2014.11.012Search in Google Scholar PubMed
9. Yoo H, Ku SK, Kim SW, Bae JS. Early Diagnosis of Sepsis Using Serum Hemoglobin Subunit Beta. Inflammation 2014 Oct 23. [Epub ahead of print].10.1007/s10753-014-0043-7Search in Google Scholar PubMed
10. Hjortrup PB, Haase N, Treschow F, Møller MH, Perner A. Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis. Acta Anaesthesiol Scand 2015;59:25-34.10.1111/aas.12427Search in Google Scholar PubMed
11. Ronco C, Legrand M, Goldstein SL, Hur M, Tran N, Howell EC, et al.Neutrophil gelatinase-associated lipocalin: Ready for routine clinical use? An international perspective. Blood Purif 2014;37:271-85. 10.1159/000360689Search in Google Scholar PubMed PubMed Central
© 2015
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.